Almost nobody warns you about this part. After surgery and chemotherapy, sex often feels different — drier, tighter, sometimes painful, and frequently the last thing on your mind. Nearly all of it has a physical cause, and most of it can be treated. This page explains what changed and what actually helps.
Most conversations about sex after ovarian cancer never happen. The discharge summary covers the chemotherapy cycles and the follow-up dates, and then everyone moves on. Months later a woman notices that penetration hurts, that desire has simply gone, and that she has no idea whether this is normal, permanent, or something she is allowed to bring up. It is normal, it is not permanent, and it is exactly the kind of thing an oncology follow-up appointment is for.
The main reason is mechanical rather than emotional. Treatment for ovarian cancer usually means both ovaries are removed, and the ovaries make most of a woman’s oestrogen and a meaningful share of her testosterone. Losing them does not taper anything — it stops overnight. Without oestrogen, the vaginal lining thins, produces far less natural lubrication and loses elasticity. Doctors call this genitourinary syndrome of menopause. If the uterus was removed too, the vagina ends in a surgical scar line and can be a little shorter than before. Chemotherapy adds its own layer: fatigue that outlasts the last cycle, numb or tingling hands and feet, and a body that has stopped feeling reliable.
Here is the part worth saying plainly, because waiting is the most common mistake. Hot flushes usually settle over a year or two. Vaginal tissue change does not. Left alone it slowly gets worse, and the longer painful sex continues, the more the pelvic floor tightens against it, which makes the next attempt worse still. Starting treatment early is far easier than reversing a year of avoidance. The menopause that follows ovarian cancer surgery deserves its own plan, and this is one of the main reasons why.
Natural menopause takes years. Removing both ovaries takes an afternoon. The symptoms arrive faster and hit harder, which is why they surprise women who were expecting a gentle decline.
Dryness and pain are caused by thinner, less elastic vaginal tissue with a poorer blood supply. This is a measurable physical change, not a sign of how you feel about your partner.
Unlike hot flushes, genitourinary symptoms tend to progress without treatment. That is an argument for starting something simple now rather than waiting to see.
Sexual difficulty is one of the most common consequences of gynaecological cancer treatment, and one of the least often discussed. Guidance is unambiguous about whose job it is to raise it: clinicians should initiate a conversation about sexual health with every adult treated for cancer, and revisit it as part of routine follow-up, rather than waiting for the patient to find the courage. Vaginal dryness, painful intercourse and loss of desire are named specifically among the things survivorship care is expected to ask about after ovarian cancer treatment. If nobody has asked you, the omission is theirs, not yours. Source: ASCO Clinical Practice Guideline, Interventions to Address Sexual Problems in People With Cancer (2018); NCCN Survivorship Guidelines.
“Sex is difficult now” is really six separate problems wearing one coat. They have different causes and different fixes, so it is worth knowing which ones apply to you before deciding what to try.
This is the commonest change and usually the first. Without oestrogen the vaginal lining becomes thinner and more fragile, the natural lubrication that normally appears with arousal largely stops, and the tissue loses its stretch. Women describe burning, a raw or sandpaper sensation, soreness for a day or two afterwards, and sometimes a little spotting from tissue that has grazed.
Two different products fix two different problems, and confusing them is why many women conclude that nothing works. A vaginal moisturiser is used on a schedule — every second or third day, whether or not sex is on the agenda — and slowly improves the tissue itself. A lubricant is used at the time, generously, and reduces friction during sex. You need both. Neither treats the underlying oestrogen loss, but for many women they are enough.
Pain felt at the entrance, in the first inch or two, is usually dryness plus a pelvic floor that has tightened protectively. The muscle guarding is involuntary and entirely logical: the body has learned that penetration hurts, so it braces. Unfortunately the bracing narrows the entrance further, which makes the next attempt more painful, which strengthens the reflex. This loop is the reason waiting rarely helps.
The way out is gradual and it works: lubricant, a graded set of vaginal dilators used for a few minutes several times a week, and ideally a pelvic floor physiotherapist who can teach the muscles to release rather than grip. Deeper pain, felt on thrusting rather than at entry, is a different question — it can come from a shortened vagina after hysterectomy, from adhesions after abdominal surgery, or occasionally from something that needs examining. Deep pain that is new should be reported rather than managed at home.
Almost every woman expects the oestrogen loss. Very few are told that the ovaries also produce a substantial share of her testosterone, and that removing them takes that away too. Add treatment fatigue, disturbed sleep from night sweats, and the low-grade anxiety of waiting for the next scan, and low desire is close to inevitable. It is not a character flaw and it is not indifference to your partner.
One idea helps more than any product here. For many women, particularly after treatment, desire does not arrive first and lead to arousal — it works the other way around. Interest appears after physical closeness has already begun, not before. Couples who wait for spontaneous desire to return can wait a very long time. Couples who start with unhurried touch, with penetration explicitly off the table, often find that desire turns up partway through.
Cancer-related fatigue is not ordinary tiredness and it does not resolve the week chemotherapy ends. It is a heavy, unrefreshed exhaustion that can persist for months, and it flattens libido comprehensively. Chemotherapy-induced peripheral neuropathy adds numbness, tingling or hypersensitivity in the hands and feet, which changes how touch is experienced — sometimes uncomfortably.
The practical answers are unglamorous and effective: use the hours of the day when your energy is genuinely best rather than defaulting to late at night, keep expectations for any single occasion low, and treat what is treatable. Fatigue that is not improving deserves a check for anaemia, thyroid problems and low mood at your next review. Neuropathy that is worsening should always be reported to your oncology team, because ongoing treatment decisions can be adjusted for it.
Debulking surgery leaves a long midline scar. There may be a port scar below the collarbone, a changed abdominal shape, weight that has moved, hair that has grown back a different texture, and for some women a stoma. Being seen naked by a partner for the first time after all of this is genuinely hard, and dreading it often does more to stop intimacy than any physical symptom does.
Nothing about this is vanity. Two things tend to help: seeing your own body privately and unhurriedly before being seen by anyone else, and keeping some clothing on at first if that makes the return easier — there is no rule that everything must come off. If body image is the main obstacle, say so out loud to your partner, because in the absence of an explanation people invent worse ones.
Two fears do most of the damage, and both are unfounded. The first is that sex might somehow restart the cancer or make it spread. It does not. The second is that cancer could be passed to a partner through sex. It cannot — ovarian cancer is not transmissible. The only genuine precaution is a short one: use a barrier method for about a week after each chemotherapy cycle, because small amounts of the drugs can appear in body fluids.
The pattern we see most often is a partner who has stopped initiating altogether, afraid of causing pain or of seeming to demand something. She reads the withdrawal as rejection, or as distaste for a body that has changed. He believes he is being considerate. Neither says anything for months. Naming it out loud usually dissolves it in a single conversation. If the fear underneath is about recurrence rather than about sex, that fear is worth addressing directly — see coping emotionally after an ovarian cancer diagnosis.
None of these means the cancer has returned. Each one is a reason to be examined rather than to keep guessing, and all of them are easier to sort out early than late.
Usually fragile, thinned tissue. It should still be examined once rather than assumed, particularly if it happens more than once.
Pain felt on thrusting rather than at the entrance is a different problem from dryness, and it warrants an examination.
Thinned vaginal tissue is more prone to infection. Infections are common, easily treated, and not something to wait out.
If moisturiser and lubricant used properly have not helped, you need an examination and probably pelvic floor physiotherapy — not more of the same.
Report this promptly to your oncology team. It belongs in a follow-up review rather than in a conversation about intimacy.
If nothing you used to enjoy appeals any more, treat that first. It is treatable, and desire rarely returns while it is untreated.
Bring it up even if the appointment is about something else. A survivorship review is meant to cover this, and your clinician will not be surprised by the question.
A 45-minute consultation, an examination only if you want one, and a plan you can start this week. Sexual health is part of survivorship care at CION, not an awkward extra.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
Raise it at your next review, or book a free 45-minute consultation. Nobody here will be embarrassed by the question, and most of what causes this can be treated.
In roughly this order. Most women who follow the first three steps for two months notice a real difference, and those who do not then know exactly what to ask for next.
Not before sex — on a fixed rota, every second or third day, indefinitely. This is the single change that helps most women most, and it works by improving the tissue itself rather than by masking friction. Give it six to eight weeks before judging it, and keep using it once things improve, because the benefit stops when the product does. Choose a plain, unperfumed vaginal moisturiser; anything scented tends to irritate thin tissue.
A separate product with a separate job. Water-based lubricants wash off easily and are fine with condoms; silicone-based ones last much longer and suit prolonged or drier sex, but should not be used with silicone dilators. Avoid petroleum jelly and anything perfumed, warming or flavoured. Reapply during sex rather than adding a token amount at the start — the commonest error is simply using too little.
Start with the smallest dilator that goes in comfortably, use plenty of lubricant, and stay at each size for a few minutes several times a week until it is genuinely easy before moving up. The goal is teaching the pelvic floor that entry is safe, not stretching yourself open. A pelvic health physiotherapist makes this substantially faster, and is worth asking for by name at your follow-up appointment.
Where moisturiser and lubricant are not enough, low-dose local vaginal oestrogen restores the tissue in a way non-hormonal products cannot, and very little of it reaches the bloodstream. Whether it is appropriate after ovarian cancer depends on your tumour subtype, and that decision belongs to your oncologist with your pathology report in front of them, not to the internet. Some ovarian cancers are hormone-sensitive and some are not, and the answer differs accordingly. Systemic hormone replacement for surgical menopause is a related but separate conversation — see managing menopause after ovarian cancer.
Agree with your partner that penetration is off the table for a few weeks, and go back to unhurried touch with no destination. It sounds contrived and it works, because it removes the performance anxiety that has usually attached itself to every attempt. Pick a time of day when your energy is real rather than defaulting to bedtime. If you have no partner, the same principle applies alone — comfortable arousal without pain is the thing you are re-establishing.
One sentence is enough to start with your partner: “I want this back, and right now it hurts, so I need to do it differently for a while.” With your clinician, “sex has been painful since treatment and I would like help with it” is a complete sentence that no oncologist finds surprising. If you would rather not raise it face to face, write it on the form when you book your consultation.
*Nothing here replaces being examined once. Most women need a single consultation to get the plan right; after that, the plan does the work.
Survivorship care is medical oncology work, and it is delivered in-house at CION: follow-up reviews and examinations, chemotherapy and maintenance therapy, genetic counselling with BRCA and HRD testing where they are relevant, nutrition support, and the unglamorous business of managing what treatment left behind — fatigue, neuropathy, early menopause and sexual health among them. Your first consultation is free and runs to about 45 minutes, which is long enough to raise something you may have been carrying for a year.
It runs across more than 35 centres in Telangana and Andhra Pradesh, and for this particular problem that matters. A dilator and physiotherapy programme needs reviewing after a few weeks, not after a day of travel to a city hospital that you will quietly skip. Being seen near home is what makes a plan like this survive contact with real life.
Two things we would rather say upfront. First, if surgery is part of your future care, cytoreductive and other gynaecologic-oncology surgery, HIPEC and PET-CT are arranged with specialist partner centres and may be billed there, while your medical oncology care stays with us. Second, you do not have to be a CION patient to ask about this. If you were treated elsewhere and nobody has ever raised life after ovarian cancer with you, bring your discharge summary and ask. That is a legitimate reason to book, and every case that raises a clinical question goes to a tumour board rather than resting on one doctor’s view.
Free, unhurried, and open to women treated elsewhere. Long enough to cover the things that never fit into a ten-minute review.
Sexual health, menopause symptoms, fatigue and neuropathy are asked about as a routine part of survivorship review here.
Follow-up, chemotherapy and review appointments close to home, so a plan that needs revisiting in six weeks actually gets revisited.
What is done in-house and what is arranged at a partner centre is said before anything is booked. Decisions for healing, not billing.
Yes. Sex does not make ovarian cancer come back, does not make it spread, and cannot pass anything to your partner. There are only two timing rules worth knowing. After abdominal or pelvic surgery, wait until your surgical team confirms the internal wounds have healed, which is usually around six weeks. During chemotherapy, use a barrier method for about a week after each cycle, because small amounts of the drugs can appear in body fluids, and avoid penetrative sex when your blood counts are at their lowest, since that is when infection and bleeding are easiest. Beyond those two points, the limiting factor is comfort rather than safety. If sex hurts, that is a signal to change what you are doing and get help with it, not a sign that you are causing harm.
Usually because both ovaries were removed, which stops oestrogen production abruptly. Without oestrogen the vaginal lining becomes thinner and more fragile, natural lubrication largely stops, and the tissue loses elasticity. Sex then causes friction on tissue that is not built for it, so it burns, stings or feels raw afterwards. A second factor builds on the first: once penetration has hurt a few times, the pelvic floor muscles tighten protectively and narrow the entrance further. If the uterus was removed as well, the vagina can be slightly shorter, which causes a deeper ache instead. Almost all of this responds to a regular vaginal moisturiser, generous lubricant, and dilators with pelvic floor physiotherapy where guarding has set in. Pain that is deep, new and one-sided is a different matter and should be examined.
For most women it does, though usually not in the way it disappeared. The ovaries produce a meaningful share of a woman's testosterone as well as her oestrogen, so removing them lowers desire directly. On top of that sit treatment fatigue, broken sleep from night sweats, anxiety about scans, and a reasonable dread of something that has recently been painful. The most useful shift is to stop waiting for desire to arrive first. After cancer treatment, interest very often appears only once physical closeness has already started, rather than before it. Couples who begin with unhurried touch, with penetration explicitly ruled out for a while, tend to find that desire turns up partway through. Treating fatigue, low mood and painful sex properly usually does more for desire than anything aimed at desire itself.
Sometimes, and it is a question for your oncologist rather than for a website. Low-dose local vaginal oestrogen restores thinned vaginal tissue in a way that non-hormonal products cannot, and very little of it is absorbed into the bloodstream. Whether it is appropriate for you depends on your tumour subtype, because some ovarian cancers are hormone-sensitive and some are not, and on what other treatment you are taking. That is why the decision needs your pathology report in front of the doctor making it. Start with a non-hormonal vaginal moisturiser used on a schedule and a good lubricant, since for many women that is enough. If it is not, ask the question directly at your follow-up appointment rather than assuming the answer is no.
This is one of the most common patterns after cancer treatment, and it is almost always a misunderstanding rather than rejection. Partners frequently stop initiating because they are afraid of causing pain, or of seeming to ask for something during a period when everything has been about illness. From the other side, that withdrawal reads as loss of interest, or as distaste for a body that has changed. Both people then stay silent for months, each trying to protect the other. Saying it out loud usually resolves it in one conversation. It helps to be specific about what you do want rather than only about what hurts, because a partner who has been told to be careful often has no idea what is still allowed. If the conversation keeps stalling, couple or psychosexual counselling is a short, practical intervention rather than a long commitment.
Tell them. Guidance for cancer care explicitly expects clinicians to raise sexual health as part of routine follow-up, so it is a recognised part of survivorship care rather than an awkward aside. It is also practical: dryness, painful sex and low desire have specific treatments, and the ones that work best are simple and available. Bleeding after sex, new deep pain, unusual discharge, or pain that has not improved after eight weeks of using moisturiser and lubricant properly all need an examination rather than another product. If raising it face to face is difficult, write it on the appointment form or hand over a note. Nobody in an oncology clinic finds the question surprising, and most clinicians are relieved when a patient brings it up first.
The first consultation is free and runs to about 45 minutes. CION delivers medical oncology for ovarian cancer in-house: chemotherapy, maintenance therapy, follow-up and survivorship care across more than 35 centres in Telangana and Andhra Pradesh, along with genetic counselling and BRCA and HRD testing where the diagnosis or family history warrants it. Sexual health, menopause symptoms, fatigue and neuropathy are asked about as part of routine follow-up rather than left for you to raise. Cytoreductive and other gynaecologic-oncology surgery, HIPEC and PET-CT are coordinated with specialist partner centres and may be billed there, and we say so upfront rather than leaving it to be discovered later. Every case that raises a clinical question is reviewed at a tumour board.